EGF receptor targeting in therapy-resistant human tumors (Q34750359)

4 August 2017

1 reference

title

EGF receptor targeting in therapy-resistant human tumors (English)

1 reference

4 August 2017

Mathias Schmidt

1

1 reference

PubMed ID

12127860

4 August 2017

Rosemarie B Lichtner

series ordinal

2

1 reference

4 August 2017

1 February 2002

1 reference

4 August 2017

Drug Resistance Updates

1 reference

4 August 2017

5

1 reference

4 August 2017

1

1 reference

4 August 2017

11-18

1 reference

Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

1 reference

7 January 2021

Mechanisms of EGF receptor regulation in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

EGF receptor deletions define a region specifically mediating STAT transcription factor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Signalling through phosphoinositide 3-kinases: the lipids take centre stage

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Signal transduction through MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Expression of oncogenic epidermal growth factor receptor family kinases induces paclitaxel resistance and alters beta-tubulin isotype expression

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

The relevance of drug sequence in combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Analysis of the genes for oestrogen and epidermal growth factor receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Investigation of the mechanisms determining the inverse relationship between oestrogen and epidermal growth factor receptors in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

STAT signaling in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

AKT plays a central role in tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1368-7646%2802%2900004-3

7 January 2021

10.1016/S1368-7646(02)00004-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12127860